Coexpression cluster:C526
From FANTOM5_SSTAR
Full id: C526_meningioma_bile_cervical_fibrosarcoma_prostate_epidermoid_lung
Phase1 CAGE Peaks
Hg19::chr10:45295885..45295915,- | p@chr10:45295885..45295915 - |
Hg19::chr12:12094754..12094758,+ | p@chr12:12094754..12094758 + |
Hg19::chr12:1919552..1919568,+ | p@chr12:1919552..1919568 + |
Hg19::chr12:31158830..31158854,- | p1@ENST00000544329 |
Hg19::chr12:31158902..31158914,- | p2@ENST00000544329 |
Hg19::chr12:52680109..52680121,- | p@chr12:52680109..52680121 - |
Hg19::chr12:52680234..52680245,- | p@chr12:52680234..52680245 - |
Hg19::chr12:52681676..52681679,- | p6@KRT81 |
Hg19::chr12:52710803..52710809,- | p@chr12:52710803..52710809 - |
Hg19::chr14:65823553..65823594,+ | p@chr14:65823553..65823594 + |
Hg19::chr14:94582894..94582917,- | p@chr14:94582894..94582917 - |
Hg19::chr15:67391010..67391046,+ | p13@SMAD3 |
Hg19::chr1:94752932..94752936,+ | p@chr1:94752932..94752936 + |
Hg19::chr2:235107734..235107745,- | p@chr2:235107734..235107745 - |
Hg19::chr6:31304866..31304870,- | p@chr6:31304866..31304870 - |
Hg19::chr8:41523346..41523361,- | p12@ANK1 |
Hg19::chr9:16063204..16063225,+ | p@chr9:16063204..16063225 + |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0045199 | maintenance of epithelial cell polarity | 0.00317899507882246 |
GO:0030507 | spectrin binding | 0.00317899507882246 |
GO:0019049 | evasion of host defenses by virus | 0.00317899507882246 |
GO:0030011 | maintenance of cell polarity | 0.00317899507882246 |
GO:0044413 | avoidance of host defenses | 0.00317899507882246 |
GO:0051834 | evasion or tolerance of defenses of other organism during symbiotic interaction | 0.00317899507882246 |
GO:0044415 | evasion or tolerance of host defenses | 0.00317899507882246 |
GO:0051832 | avoidance of defenses of other organism during symbiotic interaction | 0.00317899507882246 |
GO:0052173 | response to defenses of other organism during symbiotic interaction | 0.00317899507882246 |
GO:0052200 | response to host defenses | 0.00317899507882246 |
GO:0015460 | transport accessory protein activity | 0.00317899507882246 |
GO:0035090 | maintenance of apical/basal cell polarity | 0.00317899507882246 |
GO:0032906 | transforming growth factor-beta2 production | 0.0050860926711619 |
GO:0007183 | SMAD protein complex assembly | 0.0050860926711619 |
GO:0032909 | regulation of transforming growth factor-beta2 production | 0.0050860926711619 |
GO:0000902 | cell morphogenesis | 0.00726499113787996 |
GO:0032989 | cellular structure morphogenesis | 0.00726499113787996 |
GO:0045197 | establishment and/or maintenance of epithelial cell polarity | 0.00726499113787996 |
GO:0008093 | cytoskeletal adaptor activity | 0.00726499113787996 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 0.00726499113787996 |
GO:0042307 | positive regulation of protein import into nucleus | 0.00726499113787996 |
GO:0035088 | establishment and/or maintenance of apical/basal cell polarity | 0.00780138013070573 |
GO:0046824 | positive regulation of nucleocytoplasmic transport | 0.00829107778830017 |
GO:0051222 | positive regulation of protein transport | 0.00839032370778676 |
GO:0019048 | virus-host interaction | 0.00839032370778676 |
GO:0045930 | negative regulation of progression through mitotic cell cycle | 0.00953389737998454 |
GO:0046332 | SMAD binding | 0.0112984359739393 |
GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 0.0127084952637695 |
GO:0042990 | regulation of transcription factor import into nucleus | 0.0127084952637695 |
GO:0042991 | transcription factor import into nucleus | 0.0127084952637695 |
GO:0042306 | regulation of protein import into nucleus | 0.0127084952637695 |
GO:0051701 | interaction with host | 0.0127084952637695 |
GO:0033157 | regulation of intracellular protein transport | 0.0127084952637695 |
GO:0016528 | sarcoplasm | 0.0132368466244668 |
GO:0016529 | sarcoplasmic reticulum | 0.0132368466244668 |
GO:0032386 | regulation of intracellular transport | 0.0132368466244668 |
GO:0051223 | regulation of protein transport | 0.014171938827264 |
GO:0007163 | establishment and/or maintenance of cell polarity | 0.014171938827264 |
GO:0046822 | regulation of nucleocytoplasmic transport | 0.014171938827264 |
GO:0009653 | anatomical structure morphogenesis | 0.0141820507980852 |
GO:0044403 | symbiosis, encompassing mutualism through parasitism | 0.0141820507980852 |
GO:0044419 | interspecies interaction between organisms | 0.0141820507980852 |
GO:0007346 | regulation of progression through mitotic cell cycle | 0.0141820507980852 |
GO:0051649 | establishment of cellular localization | 0.0150403730467866 |
GO:0051641 | cellular localization | 0.0154574110135078 |
GO:0051050 | positive regulation of transport | 0.0157400659191755 |
GO:0001817 | regulation of cytokine production | 0.0166199002548351 |
GO:0006919 | caspase activation | 0.0182555558036227 |
GO:0001666 | response to hypoxia | 0.0186594158055212 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 0.0186735604828549 |
GO:0043280 | positive regulation of caspase activity | 0.0186735604828549 |
GO:0030308 | negative regulation of cell growth | 0.0194041235616757 |
GO:0045792 | negative regulation of cell size | 0.0194041235616757 |
GO:0022415 | viral reproductive process | 0.0199152228069367 |
GO:0005856 | cytoskeleton | 0.0199152228069367 |
GO:0043281 | regulation of caspase activity | 0.0200257339597556 |
GO:0060090 | molecular adaptor activity | 0.0200257339597556 |
GO:0045926 | negative regulation of growth | 0.0200257339597556 |
GO:0043623 | cellular protein complex assembly | 0.0222628797508382 |
GO:0051345 | positive regulation of hydrolase activity | 0.0237125612211264 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 0.0237125612211264 |
GO:0005200 | structural constituent of cytoskeleton | 0.0256718954156682 |
GO:0016323 | basolateral plasma membrane | 0.0256718954156682 |
GO:0008632 | apoptotic program | 0.0264568667793752 |
GO:0006606 | protein import into nucleus | 0.0280929071043848 |
GO:0051170 | nuclear import | 0.0282419938406323 |
GO:0007050 | cell cycle arrest | 0.0286695842200121 |
GO:0043235 | receptor complex | 0.0301029315524942 |
GO:0051049 | regulation of transport | 0.0301029315524942 |
GO:0006887 | exocytosis | 0.0301029315524942 |
GO:0001816 | cytokine production | 0.0301029315524942 |
GO:0048856 | anatomical structure development | 0.0301029315524942 |
GO:0017038 | protein import | 0.0317645736622528 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 0.0326147506026285 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 0.0352080511178059 |
GO:0006913 | nucleocytoplasmic transport | 0.0384598581761161 |
GO:0051169 | nuclear transport | 0.0384598581761161 |
GO:0042803 | protein homodimerization activity | 0.0384598581761161 |
GO:0001558 | regulation of cell growth | 0.0389297755708393 |
GO:0016049 | cell growth | 0.0464088845566007 |
GO:0040008 | regulation of growth | 0.0464088845566007 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 0.0464088845566007 |
GO:0008361 | regulation of cell size | 0.0464088845566007 |
GO:0005667 | transcription factor complex | 0.0464088845566007 |
GO:0006917 | induction of apoptosis | 0.0464088845566007 |
GO:0005515 | protein binding | 0.0464088845566007 |
GO:0012502 | induction of programmed cell death | 0.0464088845566007 |
GO:0006605 | protein targeting | 0.0469516159730965 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 0.0473725810133215 |
GO:0045786 | negative regulation of progression through cell cycle | 0.0473725810133215 |
GO:0005882 | intermediate filament | 0.0478500585324665 |
GO:0045111 | intermediate filament cytoskeleton | 0.0478500585324665 |
GO:0043232 | intracellular non-membrane-bound organelle | 0.0478500585324665 |
GO:0043228 | non-membrane-bound organelle | 0.0478500585324665 |
GO:0045045 | secretory pathway | 0.0478500585324665 |
GO:0043085 | positive regulation of catalytic activity | 0.0498376766578191 |
GO:0043065 | positive regulation of apoptosis | 0.0498376766578191 |
GO:0043068 | positive regulation of programmed cell death | 0.0498376766578191 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.